These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cardiopulmonary effects of norepinephrine and propranolol. Oskoui M, Aviado DM. Eur J Pharmacol; 1969 Mar; 5(4):321-7. PubMed ID: 5786356 [No Abstract] [Full Text] [Related]
6. Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action. Côté P, Polumbo RA, Harrison DC. Cardiovasc Res; 1974 Nov; 8(6):721-30. PubMed ID: 4457225 [No Abstract] [Full Text] [Related]
7. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug. Boissier JR, Giudicelli JF, Viars P, Advenier C, Mouille P, Larno S. Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548 [No Abstract] [Full Text] [Related]
8. Cholinergic mechanisms on the heart and coronary circulation. Blesa MI, Ross G. Br J Pharmacol; 1970 Jan; 38(1):93-105. PubMed ID: 5413294 [Abstract] [Full Text] [Related]
11. Evaluation of sympathetic beta-receptor blockade by recording the rate of ventricular pressure rise in cats. Benfey BG, Greeff K, Heeg E. Br J Pharmacol Chemother; 1967 May; 30(1):23-9. PubMed ID: 4382675 [No Abstract] [Full Text] [Related]
12. Effect of dehydroemetine on myocardial circulation and contractility in vivo. Salako LA, Durotoye AO. Eur J Pharmacol; 1973 Jul; 23(1):6-12. PubMed ID: 4733772 [No Abstract] [Full Text] [Related]
13. Influence of propranolol and ICI 50,172 on the cardiovascular actions of catecholamines as modified by ergotamine. Osswald W, Guimarães S, Garrett J. J Pharmacol Exp Ther; 1970 Aug; 174(2):315-22. PubMed ID: 5451366 [No Abstract] [Full Text] [Related]
14. A comparison of the cardiovascular actions of indoramin, propranolol, lignocaine, and quinidine. Alps BJ, Borrows ET, Johnson ES, Staniforth MW, Wilson AB. Cardiovasc Res; 1972 May; 6(3):226-34. PubMed ID: 4338471 [No Abstract] [Full Text] [Related]
15. Action of propranolol on the dog heart. Harry JD, Kappagoda CT, Linden RJ, Snow HM. Cardiovasc Res; 1973 Nov; 7(6):729-39. PubMed ID: 4785546 [No Abstract] [Full Text] [Related]
16. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR). Weiss L, Lundgren Y, Folkow B. Acta Physiol Scand; 1974 Aug; 91(4):447-57. PubMed ID: 4154700 [No Abstract] [Full Text] [Related]
17. Acute effects of increased serum osmolality on left ventricular performance. Wildenthal K, Mierzwiak DS, Mitchell JH. Am J Physiol; 1969 Apr; 216(4):898-904. PubMed ID: 5775886 [No Abstract] [Full Text] [Related]
18. Effect of the hypotensive drug ST 155 (Catapres) on the heart and peripheral circulation. Nayler WG, Price JM, Swann JB, McInnes I, Race D, Lowe TE. J Pharmacol Exp Ther; 1968 Nov; 164(1):45-59. PubMed ID: 5722106 [No Abstract] [Full Text] [Related]
19. Ability of glucagon to produce cardiac stimulation without arrhythmias in halothane-anaesthetized animals. Katz RL, Hinds L, Mills CJ. Br J Anaesth; 1969 Jul; 41(7):574-8. PubMed ID: 5798835 [No Abstract] [Full Text] [Related]
20. The determination of the inotropic effect of exposure of dogs to bromotrifluoromethane and bromochlorodifluoromethane. Van Stee EW, Diamond SS, Harris AM, Horton ML, Back KC. Toxicol Appl Pharmacol; 1973 Dec; 26(4):549-58. PubMed ID: 4771604 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]